These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

558 related items for PubMed ID: 198601

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)].
    Koschinsky T, Gries FA, Schwandt P, Weisweiler P, Hansen W, Nijssen J, Beckmann R.
    MMW Munch Med Wochenschr; 1977 May 20; 119(20):701-4. PubMed ID: 195201
    [Abstract] [Full Text] [Related]

  • 26. Lipoprotein composition and lipoprotein interrelations in 50-year-old men with hyperlipoproteinaemia.
    Vessby B, Hedstrand H, Olsson U.
    Ups J Med Sci; 1976 May 20; 81(2):71-8. PubMed ID: 183321
    [Abstract] [Full Text] [Related]

  • 27. Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease.
    Vessby B, Lithell H, Gustafsson IB, Borberg J.
    Atherosclerosis; 1979 Aug 20; 33(4):457-77. PubMed ID: 228684
    [Abstract] [Full Text] [Related]

  • 28. Lipid composition of serum lipoproteins in patients with primary type IIb and type IV hyperlipoproteinemia.
    Weisweiler P, Schwandt P.
    Atherosclerosis; 1978 Sep 20; 31(1):53-8. PubMed ID: 213086
    [Abstract] [Full Text] [Related]

  • 29. [Familial hyperlipoproteinemia type III].
    Patsch JR, Patsch W, Sailer S, Braunsteiner H.
    Dtsch Med Wochenschr; 1976 Oct 29; 101(44):1612-9. PubMed ID: 185039
    [No Abstract] [Full Text] [Related]

  • 30. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
    Nye ER, Sutherland WH, Temple Wa.
    N Z Med J; 1980 Nov 12; 92(671):345-9. PubMed ID: 6935550
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Treatment of hyperlipoproteinemia type IIa with a "prudent" diet and clofibrate (author's transl)].
    Mertz DP, Suermann J.
    Med Klin; 1978 Jun 09; 73(23):867-73. PubMed ID: 207959
    [Abstract] [Full Text] [Related]

  • 34. [Xantinol-nicotinate in primary type-V hyperlipoproteinaemia (author's transl)].
    Haacke H, Parwaresch MR, Mäder C.
    Dtsch Med Wochenschr; 1976 Sep 24; 101(39):1413-7. PubMed ID: 185036
    [Abstract] [Full Text] [Related]

  • 35. Influence of clofibrate on blood viscosity in primary hyperlipoproteinemia.
    Arntz HR, Leonhardt H, Dreykluft HR.
    Klin Wochenschr; 1979 Jan 01; 57(1):43-7. PubMed ID: 215822
    [Abstract] [Full Text] [Related]

  • 36. Dietary and drug treatment of primary hyperlipoproteinemia.
    Ann Intern Med; 1972 Aug 01; 77(2):267-94. PubMed ID: 4345081
    [No Abstract] [Full Text] [Related]

  • 37. Composition of low-density lipoprotein in children with hyperlipoproteinaemia.
    Bagnall TF, Lloyrd JK.
    Clin Chim Acta; 1975 Mar 24; 59(3):271-6. PubMed ID: 165017
    [Abstract] [Full Text] [Related]

  • 38. Hypolipidaemic agents: What are they good for?
    Manninen V, Mälkönen M, Tuomilehto J.
    Lancet; 1977 Dec 17; 2(8051):1281-2. PubMed ID: 73969
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.